InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,268.56
(
0.14%
)
US TECH 100
22,219.60
(
0.23%
)
Dow Jones
44,459.65
(
0.20%
)
Brent Oil
68.37
(
-0.34%
)
Bitcoin
117,271.78
(
-2.19%
)
Post# of 775952
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Doc logic

Send PM Follow Ignore
Followers 176
Posts 15112
Boards Moderated 1
Alias Born 01/26/2016

Doc logic

Re: olekbolek post# 772079

Wednesday, 06/18/2025 12:57:47 PM

Wednesday, June 18, 2025 12:57:47 PM

Post# of 775952
olekbolek,

When NWBO and long investors are waiting for the price sustaining news of validation, nothing else matters to share price until that news. What needs to be done to get there can’t be sped up by anyone so everyone is left to wait. No one wants to hear they need to wait without a set date so NWBO remains mostly silent.
Sharing their preparations for what is to come does not move the needle as the recent presentations prove. Those saying PRs help share price just got proved wrong and NWBO proved correct that they get attacked. The day of the presentation the price went down so I guess FeMike wasn’t buying in support of the company PR ; ). Some did try to support but that got shot down quickly. We wait, patiently or impatiently, we wait; ). Best wishes.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM

VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM

Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM

Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM

Start posting your company's news
Only $200 per official company press release!